The Ets-1 transcription factor controls the development and function of natural regulatory T cells by Mouly, Enguerran et al.
Article
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 207 No. 10  2113-2125
www.jem.org/cgi/doi/10.1084/jem.20092153
2113
Ets-1 is the founding member of a family of 
winged  helix-turn-helix  transcription  factors 
that was initially found as part of a fusion pro-
tein in the E26 avian erythroblastosis virus 
(Leprince et al., 1983; Nunn et al., 1983). The 
Ets domain, which is shared by all ETS pro-
teins, specifically recognizes DNA sequences that 
contain a GGAA/T core element (Nye et al., 
1992). Ets-1 is involved in multiple biological 
processes such as hematopoiesis, angiogenesis, 
or tumor progression (Dittmer, 2003). Analy-
ses  of  mice  bearing  an  Ets-1–deficient  lym-
phoid system have shed light on the complex 
functions performed by this transcription factor. 
Ets-1–deficient (Ets-1/) mice have impaired 
pre–B cell receptor–dependent stage of B cell 
maturation, decreased response to B cell recep-
tor cross-linking, and compromised develop-
ment of marginal zone and B1a B cells (Eyquem 
et al., 2004b). Furthermore, lack of functional   
Ets-1 allows the massive development of plasma   
cells, which is associated with hypersecretion   
of  IgM  and  production  of  autoantibodies   
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Regulatory T cells (T reg cells) constitute a population of CD4+ T cells that limits immune 
responses. The transcription factor Foxp3 is important for determining the development 
and function of T reg cells; however, the molecular mechanisms that trigger and maintain 
its expression remain incompletely understood. In this study, we show that mice deficient 
for the Ets-1 transcription factor (Ets-1/) developed T cell–mediated splenomegaly and 
systemic autoimmunity that can be blocked by functional wild-type T reg cells. Spleens of 
Ets-1/ mice contained mostly activated T cells, including Th2-polarized CD4+ cells and 
had reduced percentages of T reg cells. Splenic and thymic Ets-1/ T reg cells expressed 
low levels of Foxp3 and displayed the CD103 marker that characterizes antigen-experienced 
T reg cells. Thymic development of Ets-1/ T reg cells appeared intrinsically altered as 
Foxp3-expressing cells differentiate poorly in mixed fetal liver reconstituted chimera and 
fetal thymic organ culture. Ets-1/ T reg cells showed decreased in vitro suppression 
activity and did not protect Rag2/ hosts from naive T cell–induced inflammatory bowel 
disease. Furthermore, in T reg cells, Ets-1 interacted with the Foxp3 intronic enhancer and 
was required for demethylation of this regulatory sequence. These data demonstrate that 
Ets-1 is required for the development of natural T reg cells and suggest a role for this 
transcription factor in the regulation of Foxp3 expression.
© 2010 Mouly et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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transcription factor, which is activated by the IL-2–Jak3 signal-
ing pathway, plays a key role by directly activating the expres-
sion of the Foxp3 locus through two main specific elements, 
CNS1 and CNS2 (Burchill et al., 2007, 2008; Yao et al., 2007). 
TIEG1 (TGF-–inducible early gene 1; also known as KFl10) 
was shown to bind to the Foxp3 promoter and to cooperate 
with itchy E3 ubiquitin protein ligase homologue (ITCH) to 
induce Foxp3 expression (Venuprasad et al., 2008). In addition, 
the TGF-–induced transcription factor SMAD3 (mothers 
against decapentaplegic homologue 3) was reported to control 
the activity of a specific Foxp3 intronic enhancer element in co-
operation with NFAT (Tone et al., 2008). Interestingly, stable 
up-regulation of Foxp3 expression is correlated with epigenetic 
events such as DNA demethylation that are lacking in Foxp3-
positive in vitro TGF-–activated T cells (Polansky et al., 2008). 
Thus, identification of factors that contribute to the regulation 
of the Foxp3 gene appears critical to better define the T reg cell 
compartment. In this study, we investigated the function of   
Ets-1 in the development of T reg cells and further analyzed the 
role of these cells in the development of autoimmunity in mice.
RESULTS
Mice lacking Ets-1 display splenomegaly, constitutive T cell 
activation, and spontaneous Th2 cytokine expression
In the C57BL/6 background, complete inactivation of the 
Ets-1 locus leads to >98% perinatal mortality (Eyquem et al., 
2004a), whereas in mixed 129sv/C57BL/6 background, 12% 
of the mice reach adulthood. 6-wk-old viable Ets-1/ mice 
had dramatically enlarged spleens (Fig. 1 A) containing an 
approximately fourfold higher total cell number than WT 
littermate controls (Table S1). This increase was essentially 
accounted for by B cells (fourfold) and a high side scatter 
heterogeneous population (Fig. S1 A) that included eosino-
phils (not depicted).
In contrast, the number of T cells was reduced twofold as 
compared with controls (Table S1), and the reduction affected 
both CD4 and CD8 subsets (Fig. 1 B). Most CD4+ and CD8+ 
Ets-1/ splenocytes were large (Fig. 1 C), and an increased 
percentage  had  an  activated  phenotype  with  up-regulated 
levels of CD44 and down-regulation of CD62-L (Fig. 1 B). 
Notably, cells with a naive phenotype (CD62-LhighCD44low) 
represented at best 2% and 15%, respectively, of the CD4 and 
CD8 T cell populations (Fig. 1 B). Furthermore, the percent-
ages of CD69- and CD95-expressing cells were significantly 
increased in Ets-1/ T cells (Fig. S1 B). Moreover, DNA 
content analysis revealed a 1.5–2-fold increase of the percentage 
of cycling cells (Fig. 1 C).
Analysis by semiquantitative RT-PCR of the transcrip-
tion status of several cytokines in freshly isolated Ets-1/ 
CD4+ T cells revealed high expression levels of IL-4, IL-5, 
IL-10, and IL–13 but not IFN- (Fig. 1 D). Consistently, upon 
in vitro stimulation, secretion of IL-4 and IL-10 was mark-
edly increased, whereas IL-2 and IFN- were barely de-
tected (Fig. S2).
These results show that inactivation of the Ets-1 transcrip-
tion factor induces splenomegaly and the development of 
(Bories et al., 1995; Wang et al., 2005). In addition, we have 
shown that Ets-1/ mice displayed impaired expansion of 
double-positive (DP) thymocytes and defective allelic exclu-
sion at TCR- locus, suggesting a role of Ets-1 in pre-TCR 
function. Maturation of peripheral T cells also requires func-
tional Ets-1 as mice carrying a hypomorphic mutation of this 
transcription factor displayed impaired Th1 T cell fate and 
enhanced Th17 differentiation (Grenningloh et al., 2005; 
Moisan et al., 2007).
Autoimmune disease is a consequence of the generation 
of self-reactive T cells. Although a key mechanism whereby 
dysregulated T cell responses are avoided in large part through 
intrathymic deletion of self-reactive clones, additional mech-
anisms are also critical. Among those is active regulation by a 
subset of CD4+ T cells, called regulatory T cells (T reg cells), 
which is characterized by the transcription factor Foxp3 
(Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003). 
T reg cells possess robust immunosuppressive activities, and 
their absence or impaired function results in lymphoprolifer-
ation and multiorgan autoimmunity in mice and IPEX (immuno-
dysregulation polyendocrinopathy enteropathy X linked) in 
humans (Ochs et al., 2007).
Most T reg cells are generated in the thymus where the 
synergistic action of several pathways downstream of the TCR, 
costimulatory molecules, and cytokine receptors is required 
for the active transcription of Foxp3 and the differentiation of 
thymocytes into the T reg cell lineage. First, self-antigens in-
duce or favor the differentiation of CD4+CD8+ thymocytes 
into T reg cells through TCR- and CD28-dependent signals 
(Bensinger et al., 2001; Aschenbrenner et al., 2007). The sec-
ond pathway involves IL-2/IL-15 signaling as Foxp3+ T reg 
cell development in Il2r/, Il2r/, and Il2/ × Il15/ 
mice is dramatically impaired (Burchill et al., 2007). More 
recently, TGF- was also shown to be required for the gen-
eration of thymic T reg cells (Liu et al., 2008). In the periph-
ery, several mechanisms contribute to increase or sustain T reg 
cell numbers. Conversion of naive CD4+ T cells into Foxp3-
expressing T reg cells (iTreg) has been shown to occur through 
the action of TGF- in the absence of other proinflamma-
tory cytokines (Chen et al., 2003). TGF- is thought to be 
involved in the maintenance of peripheral T reg cells as re-
duced numbers of Foxp3+ T reg cells have been reported in 
both Tgf1/ mice and in mice with a T cell–specific deletion 
of Tgfr2 (Marie et al., 2005, 2006; Li et al., 2006). Further-
more, using sophisticated reconstitution mouse models, CD28 
and IL-2 signaling were shown to participate in peripheral 
T reg cell homeostasis, in addition to their role in thymic de-
velopment (Tai et al., 2005).
In mice, transcription factors acting downstream of the 
TCR and cytokine receptors contribute to drive and main-
tain expression of Foxp3 by interactions with specific regu-
latory sequences (Huehn et al., 2009; Hori, 2010). TCR 
activation results in the binding of CREB (cyclic adenosine 
monophosphate–responsive element–binding protein) to an 
intronic enhancer element (hereafter referred to as CNS2)   
in the Foxp3 gene (Kim and Leonard, 2007). The STAT5 JEM VOL. 207, September 27, 2010 
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bear a significant subset (33%) of naive CD44low 
CD62-L+CD4+ T cells, KO/CD3 chimeras, like 
Ets-1/  mice,  displayed  increased  percentages   
of activated CD44highCD4+ cells and very few 
CD44lowCD62-L+CD4+ splenocytes (Fig. 2 B).
Whereas WT/CD3 spleens had a normal fre-
quency of marginal zone (CD21+CD23) B cells, 
this population was undetectable in KO/CD3 chi-
meras (Fig. 2 C). In these mice, the CD86 and 
MHC II on B cells was significantly higher than in 
control chimeras (Fig. 2 D), indicating that most   
B cells were in an activated state.
WT/CD3  mice  had  normal  levels  of  IgM, 
IgG1, and IgE (Fig. 2 E). In KO/CD3 chimeras, 
IgM titers were similar to controls, but IgG1 and IgE titers 
were 10-fold increased (Fig. 2 E and not depicted). Fur-
thermore, elevated concentrations of anti-DNA antibodies 
could be specifically detected in KO/CD3 chimeras (Fig. 2 E). 
These results demonstrate that except for IgM levels, Ets-1/ 
T cells trigger all the features of B cell dysregulation ob-
served in Ets-1/ mice.
WT T reg cells inhibit Ets-1/ T cell–mediated 
splenomegaly and B cell autoimmune disorders
Enhanced in vivo T cell activation can originate from im-
paired development or loss of function of naturally occurring 
T reg cells. To test whether a similar process occurs in Ets-1/ 
mice, we generated Ets-1/CD3 chimeras that received (or 
not) WT Ly5.1 CD25+CD4+ (hereafter referred to as donor 
T reg cells) at the time of fetal thymus transplantation.
As expected, 5–6 wk after graft, KO/CD3 chimera mice had 
enlarged spleens compared with WT/CD3 controls (Fig. 3 A). 
Strikingly, injection of donor T reg cells in KO/CD3 chi-
meras was sufficient to block development of splenomegaly   
(Fig. 3 A). Interestingly, in these chimeras, donor T reg cells 
represented 50–60% of the CD4+ T cell population as compared 
activated T cells with CD4+ cells expressing high levels of 
Th2 cytokines. These features were associated with severe 
naive T cell lymphopenia.
Ets-1–deficient T cells trigger clearance of marginal  
zone B cells, B cell activation, and elevated serum levels  
of IgG1 and IgE
In line with previous descriptions (Eyquem et al., 2004b), histo-
logical analysis of Ets-1/ spleens showed a marked abnor-
mal structure with loss of B cell follicles and marginal zones 
(Fig. S3). Viable mutant mice contained high numbers of ac-
tivated B cells, a slight increase in the percentage of cycling 
cells (unpublished data), and high serum titers of IgM, as well 
as elevated levels of auto antibodies (Eyquem et al., 2004b).
To specifically assess a direct role of mutant T cells in the 
B cell immune disorder of Ets-1/ mice, CD3-–deficient 
mice were engrafted with Ets-1/ (KO/CD3) or WT Ets-1+/+ 
(WT/CD3) fetal thymi under the kidney capsule. 5–6 wk 
after graft, both KO/CD3 and WT/CD3 mice had recon-
stituted CD4 and CD8 splenic T cell compartments (Fig. 2 A). 
Similar to Ets-1/ mice, the KO/CD3 chimeras had spleno-
megaly (see next paragraph). Although spleens from WT/CD3   
Figure 1.  Splenomegaly and Th2-activated T cells  
in Ets-1/ mice. (A) Spleens removed from 5–6-wk-old 
Ets-1/ and WT (Ets-1+/+) littermate controls. Results are  
representative of at least five animals. (B) Spleen cell popu-
lations from Ets-1/ and Ets-1+/+ mice were stained with 
the indicated antibodies and analyzed by flow cytometry. 
Numbers indicate the percentages of cells falling in each 
quadrant. Dot plots are gated on the indicated population. 
(C, top) Forward light scatter (FSC) of CD4+ or CD8+ gated 
spleen cell populations from Ets-1/ and Ets-1+/+ littermate 
controls. (bottom) DNA content analysis of sorted CD8 and CD4 
spleen cells from Ets-1/ and Ets-1+/+ littermate controls. 
Numbers indicate percentages of cells within gates.  
(D) Semiquantitative RT-PCR analysis of cytokines. cDNA from 
freshly purified CD4+ spleen cells from Ets-1+/+ and Ets-1/ 
mice was 10-fold serially diluted and subjected to semiquan-
titative RT-PCR analysis using oligonucleotides correspond-
ing to the indicated genes. Results are representative of at 
least three independent experiments.2116 Ets-1 is needed for natural T reg cell development | Mouly et al.
naive (CD44lowCD62-L+) cells (Fig. S4 A). To further inves-
tigate the function of WT T reg cells on Ets-1/ T cells, 
CD45.2+CD4+ was sorted from WT/CD3 or KO/CD3 chi-
meras that had received (or not) CD45.1 WT T reg cells. 
Real-time RT-PCR analysis showed a 12-fold reduction of 
IL-4 expression in Ets-1/ CD4+ splenocytes that were iso-
lated from mice containing WT T reg cells compared with 
those that did not receive suppressive cells (Fig. S4 B).
Furthermore, whereas no CD21+CD23 marginal zone 
B cells were detected in the spleen of KO/CD3 chimeras, 
injection of WT T reg cells clearly prevented clearance of 
this B cell subset (Fig. 3 B). Injection of WT T reg cells also 
prevented IgG1 and IgE hypergammaglobulinemia in KO/CD3 
chimeras (Fig. 3 C). These results demonstrate that Ets-1/ 
with 13–22% in WT/CD3 controls (Fig. S4 A). In addition, 
Ets-1/ CD4+ T cells represented only 2% of total spleen 
cells in KO/CD3 chimeras that received T reg cells com-
pared with 7% in the absence of donor T reg cells, suggesting 
that donor T reg cells might inhibit expansion of Ets-1/ 
T cells. Notably, the CD4 T cell compartment of KO/CD3 
chimeras that received donor T reg cells was also devoid of 
Figure 2.  Ets-1/ T cells induce B cell activation and IgG1 and 
IgE hypergammaglobulinemia. Spleen cell population from CD3/, 
WT (C57BL/6), CD3/ engrafted with WT embryonic thymus (WT/CD3), 
and CD3/ engrafted with Ets-1/ embryonic thymus (KO/CD3) were 
analyzed by flow cytometry. (A) Dot plots are gated on whole splenocytes. 
(B) Dot plots are gated on CD4+ spleen cells. Numbers represent the per-
centage of cells falling in each quadrant. (C) Dot plots are gated on B220+ 
cells. Percentages of cells falling into the indicated gate are shown.  
(D) CD86 and MHC class II molecules on the surface of gated B220+ spleen 
cells from CD3/ chimera mice engrafted with WT (WT/CD3) thymus 
correspond to thin lines, and mice engrafted with Ets-1/ (KO/CD3) thy-
mus correspond to thick lines. These results are representative of three 
independent experiments. (E) Serum Ig levels of WT or Ets-1/ (KO) mice 
or CD3/ recipient mice engrafted with WT (WT/CD3) or Ets-1/ (KO/CD3) 
embryonic thymus. Ig levels were measured 6 or 8 wk after transfer when 
indicated (0). ELISA was used to detect anti-DNA antibodies in the serum 
of mice. Values are indicated as OD. Results are representative of four 
independent experiments. Error bars indicate standard deviation.
Figure 3.  WT T reg cells inhibit immune defects triggered by  
Ets-1/ T cells. (A) Spleens removed from 5–6-wk-old CD3/ mice 
engrafted with WT embryonic thymus and CD3/ engrafted with Ets-1/ 
embryonic thymus (KO). +Tr indicates that WT Ly5.1 CD4+CD25+ cells were 
injected on the day of thymus engraftment. (B) Dot plots show B220+ 
gated spleen cells from CD3/ mice engrafted with thymus alone (left) 
or thymus plus WT CD4+CD25+ (right). The percentage of marginal zone  
B cells (boxed) is indicated in each dot blot. Results are representative of 
three independent experiments. (C) Serum IgG1 and IgE in mice shown in A. 
Results are representative of three animals of each type. Error bars indicate 
standard deviation.JEM VOL. 207, September 27, 2010 
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Codevelopment of WT and Ets-1/ fetal liver cells does not 
alter the development of WT T reg cells nor rescues normal 
generation of Ets-1/ T reg cells
To evaluate the cell-intrinsic role of Ets-1 in T reg cells, we 
cotransferred various ratios of WT (CD45.1+) and Ets-1/ 
(CD45.2+) fetal liver cells into irradiated Rag/c/ mice. 
In 1:1 WT/KO chimera, analyzed 1 mo after transfer when 
T cells were still poorly detected in peripheral blood, the 
T cells are responsive to T reg cell suppression and point toward 
a defective T reg cell compartment in Ets-1–deficient mice.
Reduced Foxp3 expression in Ets-1/ CD4+ T cells
Based on the aforementioned observations, we studied the 
thymic and peripheral T reg cell compartments of Ets-1/ 
mice. As previously reported (Bories et al., 1995; Eyquem et al., 
2004a), the thymus of these mice had 10–12 times lower cell 
numbers, and although CD4+8+ thymocytes represented 
around 50% of the cells, the percentage of CD4+ single-positive 
(SP) thymocytes was comparable to age-matched littermates 
(Fig. 4 A). Within this subset, cells expressing Foxp3 were 
detected in mutant mice at frequencies similar to those of 
littermates. However, the amounts of Foxp3 were clearly 
lower in Ets-1/ thymocytes (Fig. 4 A), whereas CD25 was 
expressed at normal levels (not depicted).
In the spleen, the percentage of Foxp3+ cells among 
Ets-1/ CD4+ splenocytes was fourfold lower than in con-
trols (Fig. 4 A). The expression level of Foxp3 and the quan-
tity of Foxp3 transcripts in sorted Ets-1/ CD25+CD4+ cells 
were also decreased (Fig. 4 A). In contrast, expression levels 
of CD25 within Foxp3+ were equivalent in mutants and 
controls (Fig. 4 A).
Because in Ets-1/ mice 98% of the peripheral CD4+ 
T cells were activated, we determined the frequency of Ets-1/ 
Foxp3+CD4+ splenocytes that expressed CD103, a marker 
which is normally up-regulated in activated T reg cells infil-
trating nonlymphoid tissues (Sather et al., 2007). As shown in 
Fig. 4 B, 85% of T reg cells expressed CD103 (gate G2), 
compared with 28% in control and, on average, at significantly 
higher levels. In the thymus, 44% of Ets-1+/+ Foxp3+ cells 
were CD103+ and expressed high levels of this marker (Fig. 4 B, 
gate G1). Strikingly, 83% of Ets-1/ Foxp3+ thymocytes ex-
pressed CD103, although at lower levels. Given the very high 
frequency of CD103+ peripheral T reg cells and the fact that 
this marker is up-regulated on homeostatically generated 
peripheral T reg cells (Feuerer et al., 2010), these results 
raised the possibility that the majority of thymic Ets-1/ 
Foxp3+CD103+ cells might have come from the periphery. 
This would imply that thymic production of T reg cells is 
significantly reduced in Ets-1/ mice.
To investigate thymic development of T reg cells in a pe-
ripheral T cell free system, we performed fetal thymus organ 
cultures (FTOCs) with E15 thymi of Ets-1/ and WT mice. 
At day 7 of culture, WT thymic lobes had fully developed (9 × 
105 ± 105 cells/thymus), including 45–65% of DPs (median = 
50%; n = 6) and 7–25% of CD4 SP. Foxp3+ cells were readily 
identified and represented 2.5–4.5% of CD3+4+8 thymocytes 
(Fig. 4 C). In contrast, Ets-1/ lobes developed poorly (2.5 × 
105 ± 105 cells/thymus) with DPs ranging from 10 to 50% 
(median = 25%; n = 6) and 3 to 12% for CD4 SPs. Within this 
subset, Foxp3+ cells represented <0.6%, the cells express-
ing very low amounts of the Foxp3 protein. Altogether, the 
results show that, despite the normal frequency of thymic 
Foxp3-expressing cells in adults, the development of Foxp3+ 
T cell is significantly compromised in Ets-1/ mice.
Figure 4.  Impaired development of T reg cells in Ets-1/ mice.  
(A) Thymus and spleen cells from viable adult Ets-1/ (KO) mice and WT 
littermate controls were analyzed by flow cytometry. Numbers indicate 
the percentage of the gated population. Histograms show Foxp3 expres-
sion in gated CD4+Foxp3+ cells from Ets-1+/+ (blue line) and Ets-1/ 
(green line) mice. Bar graph depicts a real-time RT-PCR analysis of Foxp3 
expression in sorted CD4+CD25+ cells from spleens of Ets-1/ (KO) or 
Ets-1+/+ littermate controls (WT). Results are expressed as a Foxp3/Hprt 
ratio. Error bars indicate standard deviation. (B) Histograms show CD103 
expression in gated Foxp3+ cells from Ets-1+/+ (blue line) and Ets-1/ 
(green line) mice. The gates G1 and G2 indicate CD103-positive popula-
tions. The results in A and B are representative of at least five indepen-
dent experiments. (C) FTOCs from Ets-1/ mice and Ets-1+/+ littermates 
were analyzed by flow cytometry. Dot plots are gated as indicated. Num-
bers indicate the percentage of the gated population and are representa-
tive of six independent experiments.2118 Ets-1 is needed for natural T reg cell development | Mouly et al.
markedly increased (Fig. S7). Although the frequency of 
CD44high cells did not change, the percentage of cells that 
expressed CD62-L was reduced by half. Interestingly, a high 
frequency of Ets-1/ cells in CD4 SP was only 4.83% 
(Fig. 5 A). Strikingly, 2.04% of WT (CD45.2) CD4+ SP 
cells expressed Foxp3 at normal levels, but only 0.47% of the 
Ets-1/ (CD45.2+) counterpart stained for Foxp3 and ex-
pressed very low levels of this transcription factor (Fig. 5 A). 
The deficit of Ets-1/ T reg cells appeared even more pro-
nounced when gating on thymocytes expressing high level   
of Foxp3 (Fig. 5 A, middle). In contrast, in 1:1 WT/WT 
chimeras, normal Foxp3+ cells were readily detected in the 
CD4 SP derived from both donors. To investigate the devel-
opment of T reg cells in the presence of an excess of Ets-1/ 
cells, we analyzed 1:20 WT/KO chimera 2 mo after transfer. 
As shown in Fig. 5 B, although >75% of the CD4+ SPs was 
derived from the Ets-1/ background, the development of 
WT Foxp3+ thymocytes was not impaired and represented 
80%  of  the  T  reg  cell  subset.  This  deficit  of  Ets-1/ 
CD4+Foxp3+ cells, which resulted in an increased percentage 
of Ets-1/ CD4+Foxp3 SP cells among the CD45.2 subset, 
appeared significant in our series of chimera mice (Fig. S5). 
Collectively, these results show that the thymic environment 
in these chimeras is capable of efficiently supporting normal 
but not Ets-1/ T reg cell development and point toward an 
intrinsic role for Ets-1 in this process.
Phenotype of peripheral Ets-1/ CD4+ cells in mixed fetal 
liver chimeras
As described in the previous section, 75% of CD4+ SP thy-
mocytes in 1:20 WT/KO chimera were derived from the 
mutated background (Fig. 5 B). However, in the spleen of 
these animals, Ets-1/ cells represented <15% of CD4+ T cells 
(Fig. 6), indicating that conventional mutated CD4+ T cells 
have a significant competitive deficit compared with WT 
cells. Within the CD4+ subset, the majority of Foxp3+ was 
derived from the WT. The deficit of Ets-1/ CD4+Foxp3+ 
cells, and consequently the increased percentage of Ets-1/ 
CD4+Foxp3 splenocytes, was significant in our series of chi-
mera mice (Fig. S6). Furthermore, although around 60% of WT 
T reg cells were CD103+, 88% of Ets-1/ Foxp3+CD4+ 
expressed CD103 (Fig. 6). In contrast, 50% of the very few 
Ets-1/ Foxp3+CD4+ thymocytes expressed CD103 as com-
pared with 54% in the WT counterparts (Fig. S7 A). Thus, in 
these lymphopenic chimeras, the severe quantitative deficit 
of Ets-1/ thymic T reg cells correlated with a significantly 
lower frequency of antigen-experienced T reg cells in the 
thymus than in the periphery. This reinforced our hypothesis 
that in viable Ets-1/ mice, recirculating Foxp3+ Ets-1/ 
cells were masking a quantitative deficit in the development 
of thymic T reg cells.
We next investigated the activation status of Ets-1/ CD4+ 
and CD8+ T cells in the spleen of fetal liver chimera mice. As 
described for Ets-1 viable mice, in chimeras that only re-
ceived Ets-1/ fetal liver cells, >80% of CD4 cells were 
CD44highCD62-L, and <1% had a naive phenotype (CD62-
L+CD44low; Fig. S7). In contrast, in mixed 1:20 WT/KO 
chimera, the percentages of CD62-L+CD44high and CD62-
L+CD44low within Ets-1/ CD4+ and CD8+ subsets were 
Figure 5.  Impaired development of Ets-1/ Foxp3+ thymocytes in 
mixed fetal liver reconstituted mice. (A) Thymus cell populations from 
Rag/c/ mice reconstituted with 1:1 mixed CD45.1+ WT plus CD45.2+ 
WT or CD45.2+ Ets-1/ fetal liver cells were analyzed 1 mo after transfer. 
The gated cell population is indicated above each dot plot. Histograms 
show Foxp3 expression within CD4+ SP thymocytes gated on CD45.2 or 
CD45.2+ cells. Results are representative of three independent mice.  
In WT/WT chimera, the percentage of Foxp3+ among CD4+CD8CD45.2 
populations was not significantly different from the percentage of Foxp3+ 
among CD4+CD8CD45.2+ cells (P = 0.2262), whereas in the WT/KO mice, 
the difference was significant (P = 0.03826). (B) Thymus cell populations 
from Rag/c/ mice reconstituted with 1:20 mixed CD45.1+ WT plus 
CD45.2+ WT or CD45.2+ Ets-1/ fetal liver cells were analyzed by flow 
cytometry 2 mo after transfer. Results are representative of three inde-
pendent mice. In WT/WT chimera, the percentage of Foxp3+ among 
CD4+CD8CD45.2 populations was not significantly different from the 
percentage of Foxp3+ among CD4+CD8CD45.2+ cells (P = 0.0571), 
whereas in the WT/KO mice, the difference was significant (P = 0.00684). 
Numbers indicate the percentage of the gated populations.JEM VOL. 207, September 27, 2010 
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90% of the splenic CD4+CD62-L+ T cell population of 
Ets-1/ mice also expressed high levels of CD44, as com-
pared with 5% in the control population. Therefore, it is not 
excluded that the differences observed are caused by a differ-
ential susceptibility to anti-CD3/IL-2 and TGF- treatment 
among CD4 T cell subsets rather than a specific effect caused 
by Ets-1 inactivation. These results indicate that inactivation 
of the Ets-1 transcription factor reduces but does not abrogate 
the capacity of Ets-1/ CD4+ T cells to up-regulate Foxp3 
in vitro.
Ets-1/ T reg cells show decreased in vitro and in vivo 
suppressive activity
To examine the in vitro suppressive function of CD4+CD25+ 
spleen cells that develop in the Ets-1/ background, naive   
T cells (CD4+CD62-L+CD25) were sorted from WT C57BL/6 
mice and were activated in vitro in the presence of various num-
bers of sorted 90% Foxp3-expressing T reg cells (CD4+CD25high) 
from Rag/Ets-1+/+ or Rag/Ets-1/ chimera mice. At high 
concentrations, both WT and mutant T reg cells inhibited 
anti-CD3–induced T cell proliferation (Fig. 8 A). However, 
the suppressive activity of mutant T reg cells was less efficient 
as the same level of inhibition was achieved by four- to five-
fold fewer WT T reg cells (Fig. 8 A). Thus, Ets-1/ cells 
have a decreased in vitro suppressive activity.
To determine the importance of Ets-1 in T reg cell   
in vivo function, we used the mouse model of inflammatory 
bowel disease (IBD) by adoptively transferring WT naive   
T cells with or without cotransferring WT or Ets-1/ T reg 
cells into Rag2/ recipient mice. As expected, recipient mice 
that received WT naive CD4+CD25CD62-L+ T cells (patho-
genic) alone developed severe colitis 6–7 wk after cell trans-
fer, with thickening of the colon, loss of normal, pellet-shaped 
stools, and marked mononuclear cellular infiltrate (Fig. 8 B). 
Rag2/ mice that were cotransferred with WT CD4+CD25+ 
T reg cells and WT naive T cells were protected from devel-
oping colitis with normal pellet-shaped stools and normal 
mucosal structure. In marked contrast, Ets-1/ T reg cells 
did not prevent the development of colitis after being co-
transferred with WT naive T cells, and mice showed features 
of colitis, including thickening of the colon and mononuclear 
cellular infiltrate (Fig. 8 B).
percentage of WT T cells in chimera mice did not express a 
typical naive phenotype (CD62-L+CD44low), suggesting that 
our lymphopenic host mouse model may lead to the under-
estimation of the frequency of naive T cells (Fig. S7). Although 
spleens from 1:20 chimera contained a significant percentage 
of Ets-1/ T cells, none of them had elevated spleen cells 
numbers nor displayed splenomegaly (Fig. S7 B and not de-
picted). In contrast, mice reconstituted only with Ets-1/ 
fetal liver cells (KO chimera) were affected by both defects. 
Altogether, these results show that the presence of WT 
cells in mixed chimera is sufficient to control spleen cell 
numbers but to only partially rescue Ets-1/ naive CD4 
and CD8 splenocytes.
In vitro TGF-–mediated up-regulation of Foxp3  
is not abrogated in Ets-1/ peripheral T cells
Next, we investigated whether Ets-1/ CD4+ T cells could 
up-regulate Foxp3 after in vitro activation. CD4+CD62-L+ 
splenocytes were FACS sorted from Ets-1/ and WT mice 
and activated with anti-CD3 in IL-2– and TGF-–containing 
medium.  48  h  after  activation,  the  percentage  of  Foxp3- 
expressing cells was lower in Ets-1/ (21%) than in WT cul-
tures (50%; Fig. 7). We should note that, as shown in Fig. 1 B, 
Figure 6.  Defective Ets-1/ T reg cells in the spleen of mixed 
chimera mice. Spleen cell populations from Rag/c/ mice reconsti-
tuted with a 1:20 mixture of CD45.1+ WT plus CD45.2+ WT or CD45.2+ 
Ets-1/ fetal liver cells were analyzed by flow cytometry 2 mo after 
transfer. The same chimeras as in Fig. 5 B are shown. The gated cell popu-
lation is indicated above each dot plot. Numbers indicate the percentage 
of the gated populations. Results are representative of three independent 
experiments. In spleens of WT/WT chimera, the percentage of Foxp3+ 
among CD4+CD45.2 populations was not significantly different from the 
percentage of Foxp3+ among CD4+CD45.2+ cells (P = 0.2262), whereas in 
the WT/KO mice, the difference was significant (P = 0.03826).
Figure 7.  In vitro development of Ets-1/ T reg cells. FACS analysis 
of Foxp3 expression in in vitro stimulated naive WT (WT CD4+) or Ets-1/ 
CD4+ (KO CD4+) sorted spleen cells. Histograms show the staining of anti-
Foxp3 and isotype control (gray) antibodies. Mean fluorescent intensity 
(MFI) and the percentage of cells in the indicated gate are shown. Results 
represent four independent experiments.2120 Ets-1 is needed for natural T reg cell development | Mouly et al.
TFSEARCH  software  (http://www.cbrc.jp/research/db/
TFSEARCH.html) confirmed the presence of two conserved 
ETS-binding sites located near STAT5/CREB-interacting 
sites that were previously suggested by Floess et al. (2007; 
Fig. 9 A). Ets-1 binding to the native Foxp3 gene in mouse 
primary  cells  was  assessed  using  sorted  CD4+CD25  and 
CD4+CD25bright splenocytes and chromatin immunoprecipi-
tation (ChIP) with anti–Ets-1, anti-STAT5, or irrelevant (Ig) 
antibodies. Subsequent real-time PCR amplification of the 
Foxp3 gene surrounding putative binding sites in the CNS2 
region showed expected STAT5 but also significant Ets-1 
binding in T reg cells but not in naive cells (Fig. 9 B). Con-
versely, analysis of the Foxp3 promoter region did not reveal 
significant Ets-1 binding (Fig. 9 B). As a control, we assessed 
a DNA segment of the IgH constant region (Cµ) that is not 
expressed in T cells and found neither STAT5 nor Ets-1 
binding. To investigate the functional significance of ETS-
binding sites on the activity of CNS2, the minimal enhancer 
region (including the two ETS-binding sites) was cloned into 
the pGL3-promoter vector, and luciferase activity was mea-
sured into transfected Jurkat T cells. Whereas the intact en-
hancer exhibited an approximately sixfold increase in activity 
in response to PMA plus ionomycin, mutation of either ETS-
binding site (or both) dramatically reduced CNS2 induced 
function (Fig. 9 C). Thus, ETS-binding sites are required for 
the enhancer function of the CNS2 region. To further inves-
tigate  how  Ets-1  binding  impacted  the  Foxp3  locus,  the 
methylation status of CNS2 was analyzed by bisulphite se-
quencing on DNA isolated from male T cells (see Materials 
and methods). Interestingly, striking differences between WT 
and Ets-1/ CD4+CD25bright T cells could be observed. CpG 
motifs within our amplified sequence displayed a high degree 
of methylation (100%) within conventional CD4+CD25 
T cells from both genotypes (Fig. 9 D). However, whereas 
the amplified region was unmethylated within WT T reg cells, 
CpG dinucleotides in this region were largely methylated in 
Ets-1/ T reg cell (Fig. 9 D). This result demonstrated that 
Ets-1 is essential for epigenetic modulations associated with 
Foxp3 expression.
DISCUSSION
The data presented in this study show that Ets-1 is required 
for normal development and function of T reg cells and that 
defects in this cell subset were responsible for some of the 
immunological  disorders  in  Ets-1/  mice.  Viable  young 
mutant animals had reduced numbers of T reg cells in the spleen, 
but the frequency in the thymus appeared normal. In both 
sites, Ets-1/ T reg cells had an unusual phenotype in that 
they expressed CD103 (Fig. 4 B), a marker typical of cells that 
experienced antigen under certain inflammatory conditions 
(Huehn et al., 2004; Suffia et al., 2005). This raised the possi-
bility that the majority of thymic Ets-1/ T reg cells were 
antigen-experienced recirculating cells, thereby masking an 
important quantitative deficit in thymic development of these 
cells. This was indeed the case, as supported by the very low fre-
quency of thymic T reg cells in FTOCs (Fig. 4 C), in 5-d-old 
This result demonstrates that Ets-1/ T reg cells do not 
protect from naive T cell–induced IBD. This could be be-
cause of decreased suppressive function (as shown in vitro), 
although decreased survival of mutant T reg cells both in vivo 
and in vitro cannot be excluded.
Ets-1 binds Foxp3 transcriptional regulatory sequences  
and controls their methylation status
To further characterize the function of Ets-1 in T reg cells, 
we analyzed Foxp3 transcriptional regulatory sequences. A pre-
vious study has identified an enhancer element (CNS2) lo-
cated between exon 2b and 1 of Foxp3 that contains T reg 
cell–specific STAT5- and CREB-binding sites (Kim and 
Leonard, 2007). Furthermore, this region displays a CpG is-
land that appears to be specifically demethylated in T reg 
cells. Analysis of human and mouse enhancer regions with 
Figure 8.  Impaired suppressive activity of Ets-1/ T reg cells.  
(A) WT naive T cells (CD4+CD25CD62-L+) were stimulated with -CD3 
and APC in the presence of CD4+CD25+ cells from WT (closed triangles) or 
Ets-1/ (closed squares) Rag/ chimeric mice at the indicated ratios. 
The open diamond indicates naive T cells alone. Error bars indicate the 
standard deviation of triplicate values. Histograms show Foxp3 expression 
in sorted T reg cells from Ets-1+/+ (WT; blue) and Ets-1/ (KO; green) 
mice used for the in vitro suppression assay. Sorted CD4+ spleen cells (Tot; 
red) were stained as a control. Numbers indicate the percentage of cells 
falling into the gate indicated by the horizontal bar. Results are represen-
tative of three experiments. (B) Development of colitis 7 wk after adoptive 
cell transfer. Histological appearance of colon in representative Rag2/ 
recipient mice 7 wk after transfer WT naive T cells (NaT) alone or with 
CD4+CD25+ from WT (WT Tr) or Ets-1/ (KO Tr) mice. Sections of colon 
from individual mice were imbedded in formalin and stained with hema-
toxylin and eosin. Results are representative of four different mice of 
each type. Bar, 100 µm.JEM VOL. 207, September 27, 2010 
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newborns (not depicted), and in mixed WT/KO chimeras 
analyzed at relative early time points (Figs. 5 and 6).
Ets-1/ mice have a severe phenotype that affects other 
lymphocyte lineages. In such context, the T reg cell deficit 
could be secondary to T reg cell–independent abnormalities, 
such as the T cell lymphopenia, the hyperactivation status of 
conventional T cells, and dysfunctions resulting thereof. As 
demonstrated in this study using mixed WT/KO fetal liver 
chimeras, normal T reg cell development was achieved in   
a thymic environment even with an excess of Ets-1/ cells.   
In contrast, the same environment did not rescue the deficit of 
T reg cell development of Ets-1/ precursors, ruling out a 
potential role of extrinsic factors, e.g., IL-2 or TGF-, in this 
deficit. These results strongly supported a T reg cell–intrinsic 
role of Ets-1.
Normal T reg cells were shown to prevent Ets-1/ T cell–
mediated splenomegaly and B cell dysfunctions observed in 
viable mutants. This block correlated with decreased accu-
mulation of Ets-1/ T cells, drastic reduction in the capacity 
of mutant CD4+ T cells to produce IL-4, and significant de-
crease of the proportion of CD44highCD62-L cells to the 
benefit of activated/memory cells coexpressing high levels of 
these two molecules (Fig. S7). Moreover, cells with a naive 
phenotype (CD44lowCD62-Lhigh) were now clearly detected, 
but their frequency was still significantly lower than in controls. 
Thus, Ets-1/ conventional T cells were highly susceptible 
to key T reg cell–mediated negative signals, but the failure to 
accumulate high numbers of naive cells could indicate that 
Ets-1/ conventional CD4 T cells did not respond to T reg 
cell–mediated signals inhibiting activation or that they were 
in an intrinsic state of activation caused by the lack of Ets-1.
Although this issue is difficult to assess given the lympho-
penic context of Ets-1/ and mixed WT/KO chimeras, our 
experiments also provided evidence suggestive of cell intrin-
sic defects in conventional Ets-1/ CD4 T cells, which pro-
vide possible explanations for the distinct spectrum of immune 
disorders in these mice as compared with other T reg cell–
defective models with partial or complete impaired Foxp3 func-
tion. First, these cells had reduced growth potential and/or 
survival in vitro (Bories et al., 1995; Muthusamy et al., 1995). 
This could explain the T cell lymphopenia, despite the severe 
T reg cell deficit, instead of uncontrolled T cell expansion. 
Figure 9.  Ets-1 is involved in epigenetic changes at the Foxp3 
locus. (A) Schematic representation of the mouse Foxp3 gene. Exons are 
shown as black boxes and are labeled. The enhancer region (CNS2) con-
taining the CpG island and the promoter region (Pr) are indicated as open 
and closed circles, respectively. Comparison of mouse (m) and human (h) 
sequences of CNS2 is shown. CpG are underlined, and potential Stat 
(GAS), CREB, and Ets-1–binding sites are boxed. (B) Sorted splenic  
CD25brightCD4+ and CD25CD4+ T cells were treated with IL-2 for 1 h. ChIP 
was performed using normal rabbit serum (Ig), anti-STAT5 (Stat5), or anti–
Ets-1 (Ets1) antibodies. Quantification of immunoprecipitated DNA frag-
ments was performed by real-time PCR using primers for CNS2, the 
promoter region, and the irrelevant IgH Cµ. Values were normalized to 
corresponding input control and are expressed as fold enrichment relative 
to normal rabbit serum for each experiment. Results are representative of 
three individual experiments. (C) The conserved Ets-binding sites (indi-
cated as gray boxes) in CNS2 are essential for PMA plus ionomycin– 
induced Foxp3 enhancer activity. Mutations (shown as X) in the Ets-binding 
sites were introduced into the Foxp3 reporter construct. Constructs were 
transected into Jurkat cells, followed by no stimulation or stimulation 
with PMA plus ionomycin for 17 h. Luciferase activity was normalized to  
cotransfected -galactosidase. Bar graphs show the fold increase of  
normalized luciferase activities between the treated versus untreated 
conditions. Results are representative of four independent experiments.  
(B and C) Error bars indicate standard deviation. (D) Methylation pattern 
of Foxp3 CNS2 in CD25brightCD4+ and CD25CD4+ T cells derived from male 
Ets-1/ or Ets-1+/+ mice. The BiQ Analyzer was used to analyze the sequence 
traces from 10 independent clones from each amplified bisulfite-treated 
DNA. The methylation status of individual CpG motifs within the ampli-
fied region is colored in yellow (methylated) or blue (not methylated). 
Numbers indicate the percentage of methylation at CpG sites. Results are 
representative of three individual experiments.
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be required to efficiently target a large complex of nuclear fac-
tors to the Foxp3 intronic enhancer. However, gene-targeted 
deletion of the CNS2 region was shown to impair heritable 
Foxp3 expression in dividing cells but, unlike Ets-1 inactivation, 
not to affect the development of thymic T reg cells (Zheng 
et al., 2010). These data suggest that Ets-1 could interact with 
additional regulatory sequences within the Foxp3 locus.
The CNS1 sequence appears to be essential for TGF-–
mediated Foxp3 induction in conventional T cells but dis-
pensable for T reg cell thymic development. We show in 
this study that TGF- could induce Foxp3 expression in 
Ets-1/ T cells in vitro (Fig. 7), and because we failed to 
detect Ets-1 binding to the Foxp3 promoter (Fig. 9 B), it 
seems unlikely that neither the CNS1 nor the promoter would 
be  required  for  Ets-1–mediated  regulation  of  the  Foxp3 
gene. An additional region, CNS3, was shown to increase 
the frequency of T reg cells generated in the thymus and   
in the spleen, but its deletion left the levels of Foxp3 unaf-
fected (Zheng et al., 2010). Thus, Ets-1 may not act through 
a  single  regulatory  region  but  rather  interact  at  several   
sites, and only from these combined activities would proper 
expression and epigenetic modification at the Foxp3 locus 
be achieved.
Altogether, our data support a model in which Ets-1 par-
ticipates in a nucleoprotein complex whose function would 
be regulated by TCR and/or -chain signaling pathways to 
induce and lock up Foxp3 expression during the develop-
ment of thymic T reg cells. These results identify Ets-1 as a 
key regulator of the immune system and of the biology of 
T reg cells.
MATERIALS AND METHODS
Mice. Mice carrying the inactivated ets-1 gene have been previously de-
scribed (Bories et al., 1995; Eyquem et al., 2004a). All mice used in this 
study, including WT C57BL/6 mice, were maintained in our specific patho-
gen-free breeding facility (Departement d’Experimentation Animal, Institut 
Universitaire d’Hématologie, Saint Louis, France) and were sacrificed for 
analysis between 5 and 6 wk of age. All mouse experiments were subject to 
approval by the Institut Universitaire d’Hémathologie Institutional Animal 
Care and Use Committee.
Flow cytometry and cell sorting. Single cell suspensions were stained 
with antibodies according to standard procedures and analyzed on a FACS-
calibur or a Canto flow cytometer (BD). FACS results were analyzed with 
CellQuestpro (BD) or FlowJo software (Tree Star, Inc.). The following an-
tibodies were purchased from BD: anti–CD8- (53-6.7), anti-CD4 (L3T4), 
anti-CD25 (7D4), anti–CD3- (clone 145-2C11), anti-CD44 (IM7), anti-
CD69  (H1.2F3),  anti-CD95  (Jo2),  anti-CD95L  (MFL3),  anti–CD62-L 
(MEL-14), anti-CD103 (M290), anti-CD45.2 (104), anti-CD23 (B3B4), 
anti-CD21 (7G6), anti-CD86 (GL1), and anti–I-A/I-E (M5/114.15.2). mAbs 
were conjugated with FITC, phycoerythrin, biotin or allophycocyanin, 
Pacific blue, streptavidin PerCP-Cy5.5, and streptavidin Cy-Chrome.
Cell sorting was performed on a FACSvantage SE (BD), and in all cases, 
the purity of the sorted cells was estimated at >99%. FACS DNA content 
analysis was performed as described previously (Lagresle et al., 2002). For in-
tracellular staining of Foxp3, single cell suspensions from spleens and thymi 
were stained with anti-CD4, anti-CD8, and anti-CD25 or anti-CD3. Sub-
sequent intracellular staining for Foxp3-expressing cells was performed using 
the phycoerythrin anti-Foxp3 staining kit (eBioscience) according to the   
manufacturer’s instructions.
Second, they showed enhanced Th2 polarization but poor 
capacity to produce IFN- (Fig. 1 and Fig. S2) or to induce 
IBD in Rag2-deficient hosts (not depicted). Together with 
the absence of IBD in viable Ets-1/ mice, these results sug-
gest that inactivation of Ets-1 might negatively impact Th1 
polarization, which is in line with the finding that T-bet func-
tion was markedly impaired in Ets-1 mutated T cells, stimu-
lated under Th1-skewing conditions (Grenningloh et al., 2005). 
Collectively, these results suggest that Ets-1 inactivation also 
affects conventional T cells in a cell-intrinsic manner and 
provide an explanation for the absence of massive T cell ex-
pansions and enhanced Th2 polarization in mutant animals.
Ets-1 may regulate Foxp3 expression trough several non-
mutually exclusive ways. It could have an indirect effect by reg-
ulating the transcription of genes encoding direct regulators 
of Foxp3 or by controlling expression of signaling molecules 
acting upstream of Foxp3 (i.e., IL-2R or TCR). However, 
our finding that Ets-1 binds to the CNS2 region and that the 
enhancer activity of this element relies on ETS-binding sites 
rather supports a more direct effect. Histone modification 
and DNA demethylation have been associated with stable 
expression of Foxp3 in both thymic and peripherally gener-
ated T reg cells (Floess et al., 2007; Polansky et al., 2008).   
In this context, inactivation of nuclear factors such as Runx–
CBF- that are involved in chromatin remodeling processes 
markedly impaired the T reg cell compartment (Kitoh et al., 
2009; Klunker et al., 2009; Rudra et al., 2009). Interestingly, 
Runx–CBF-/ and Ets-1/ mice both displayed T reg cell 
deficit associated with hyper IgE secretion and enhanced Th2 
polarization (Kitoh et al., 2009). Thus, as the Runx–CBF- 
complex, Ets-1 could contribute to trigger the epigenetic 
changes required for stable Foxp3 expression. This hypothesis 
is strengthened by the highly methylated status of the CNS2 
region in splenic Ets-1/ T reg cells that correlated with the 
reduced level of Foxp3 transcripts and proteins (Figs. 4 and 9 D). 
However, although CBF- was required to maintain high 
levels of Foxp3 in the periphery, unlike Ets-1/ mice, CBF-
–deficient mice had normal thymic T reg cell development 
(Kitoh et al., 2009; Rudra et al., 2009). This suggests that Ets-1 
function may not be restricted to the context of such epigen-
etic modifier nuclear complexes.
We report in this study that functional Ets-binding sites 
within the CNS2 region are located near sequences occupied 
by STAT5 and CREB nuclear factors in T reg cells (Fig. 9 A; 
Kim and Leonard, 2007). Interestingly, Ets-1 has been shown 
to interact with STAT5 in T cells that were activated in vitro 
in the presence of IL-2 and, upon those conditions, to bind 
DNA target sites (Rameil et al., 2000). Thus, during thymic 
T reg cell development, Ets-1–STAT5 complexes could in-
teract with Foxp3 regulatory sequences, thereby ensuring 
optimal expression of the gene. Furthermore, upon cellular ac-
tivation, phosphorylated Ets-1 and CREB are both able to 
associate with CBP/p300, two proteins know to carry histone 
acetyl transferase activities (Chrivia et al., 1993; Yang et al., 
1998; Foulds et al., 2004). Thus, for thymocytes that experi-
ence strong TCR/CD28 and IL-2 signals, Ets-1 activity could JEM VOL. 207, September 27, 2010 
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PCR primers used were 5-EFoxp, 5-CACACAGTAAGAAGGTGGA-
TCCATGC-3; and 3-EFoxp 5-CTGGGCTGGCCAGCCAGCTTC-
CTGCACTGTC-3.
The site-directed mutagenesis kit (Agilent Technologies) was used to   
mutate the GGA motif into CCA in the targeted ETS sites. Primers for   
mutagenesis were as follows: FwMt E1, 5-ACGTCACCTACCTCTA-
GGGCTAGCACCCAC-3;  RvMt  E1,  5-GTGGGTGCTAGCCCT-
AGAGGTAGGTGACGT-3; FwMt E2, 5-AGCCCAATCCATGGGGC-
CGCCATGACG-3; and RvMt E2, 5-CGTCATGGCGGCCCCATG-
GATTGGGCT-3. The integrity of all the CNS2 regions inserted in the 
pGL3-Promoter vector was established by sequencing.
Transient transfections and luciferase assays. Jurkat cells were tran-
siently transfected with 1 µg of the indicated pGL3-luciferase plasmids using 
electroporation with the Cell Line Nucleofector kit V (Lonza). For each 
transfection, 0.5 µg of -galactosidase–expressing plasmid (Invitrogen) was 
added for normalization. Activation and luciferase assays were performed as 
previously described (Kim and Leonard, 2007).
ChIP assays. ChIP assays were performed using the Imprint ChIP kit (Sigma-
Aldrich) as previously described (Eyquem et al., 2002). CD4+CD25bright and 
CD4+CD25 cells were sorted from spleens and stimulated with 100 U/ml 
IL-2 for 1 h. Formaldehyde (final concentration 1%) was then added to 
cross-link proteins and DNA. The cell lysates were sonicated and immuno-
precipitated with normal rabbit serum (Millipore), -STAT5 (Santa Cruz 
Biotechnology, Inc.), and –Ets-1 (Santa Cruz Biotechnology, Inc.). The 
immunoprecipitated DNA was eluted and amplified by real-time SYBR 
green PCR using an ABI 7300 (Applied Biosystems). Values were normal-
ized to serial dilution of corresponding input controls and are expressed as 
fold enrichment relative to normal rabbit serum for each experiment. The 
sequence-specific  primers  used  for  amplification  of  the  Foxp3  gene  are 
CNS2, 5-ATCTGGCCAAGTTCAGGTTG-3 and 5-GGAACTGGT-
GTGACTGTGTGA-3; and Foxp3 promoter, 5-CACTCAGAGACTC-
GCAGCAG-3 and 5-GGGGTAGTGCTCTGTCTCCA-3. Primers for 
IgH Cµ irrelevant region are 5-GGCCTCGCAGATGAGTTTAG-3 and 
5-GTGCCCATTCCAGGTAAGAA-3.
Detection of serum Ig. Concentrations of serum polyclonal IgM, IgG1, 
IgE, and IgG2b were determined using isotype-specific ELISA (Southern-
Biotech). The concentrations were determined by comparing test sample 
dilution series with isotype control standards (SouthernBiotech). For IgE detec-
tion, the capturing antibody was anti-IgE (R35-72; BD). For detection of 
autoantibodies, the capturing agent used was double-stranded sheared salmon 
sperm DNA (Eppendorf) at 10 µg/ml.
Bisulphite sequencing. Genomic DNA was isolated from electronically 
sorted male T cells as previously described (Eyquem et al., 2002). Sodium 
bisulphite treatment of genomic DNA was performed using the QIAGEN kit 
according the manufacturer’s protocol. In a subsequent PCR amplification, 
uracils were replicated as thymidines. PCRs were performed on Eppendorf 
thermocyclers in a final volume of 25 µl containing 1× PCR buffer, 1 U Taq 
DNA polymerase (Promega), 200 µM deoxy-nucleoside triphosphate, 12.5 
pmol each of forward and reverse primers, and 7 ng of bisulphate-treated 
genomic DNA. The amplification conditions were 95°C for 15 min and 40 
cycles of 95°C for 1 min, 55°C for 45 s, and 72°C for 1 min, and a final 
extension step of 10 min at 72°C. PCR products were purified and cloned 
into Topo vectors. Plasmid from individual clones was purified and se-
quenced in both directions applying the PCR primers and the ABI Big Dye 
Terminator v1.1 cycle sequencing chemistry (Applied Biosystems), followed 
by capillary electrophoresis on an ABI 3100 genetic analyzer (Applied Bio-
systems). Trace files were interpreted using BiQ Analyzer (Max-Planck-Institut, 
Saarbrucken, Germany), which allows for quantification of methylation   
signals. For each sample, both PCR amplification and sequencing were re-
peated once. The following primers (5 to 3 direction) were used for both 
PCR amplification of bisulphite-converted genomic DNA and sequence 
In  vitro  differentiation  of  naive  T  cells  into  Foxp3-expressing 
cells. Sorted CD4+CD25CD62-L+ T cells and irradiated Rag2/ spleen 
cells (1:3 ratio) were cultured in RPMI medium containing 10% fetal calf 
serum, 5 µg/ml soluble anti-CD3 (2C11), 3 ng/ml TGF-1, and 20 U/ml 
mouse recombinant IL-2. Foxp3 expression was measured after 72 h   
of activation.
In vitro suppression activity. Sorted naive WT CD4+CD25 T cells   
(1.5 × 104 cells) were set up in triplicates in 96-well round-bottom plates 
(Costard) with 105 irradiated Rag2/ spleen cells and mixed or not with 
variable numbers of FACS sorted WT or Ets-1/ CD4+CD25high T reg 
cells to obtain the indicated ratios (T reg cells/naives) in medium containing 
5 µg/ml anti-CD3. Intracellular FACS analysis of sorted CD4+CD25high  
T reg cells revealed Foxp3 expression in >90% of the cells. Proliferation was 
assessed after 3 d by pulsing the cells with 1 µCi/well [3H] thymidine (GE 
Healthcare) for the last 16 h of culture. Cells were harvested onto filter 
membranes, and the amount of incorporated [3H] thymidine was measured 
with a liquid scintillation counter Wallac1409 (PerkinElmer). Data are rep-
resentative of three independent experiments.
In vivo cell transfer. All mice used for chimera were in a C57BL/6 back-
ground. CD45.2/CD45.1 Rag2/c/ chimera mice were generated as 
previously described (Eyquem et al., 2004b). For T cell reconstitution of 
CD3-–deficient  mice,  thymi  were  isolated  from  18.5  pc  embryos  and 
grafted under the kidney capsule of CD3/ mice. 5–6 wk after transfer, 
recipient chimera mice were sacrificed for analysis. For T reg cell transfers, 
spleen cell suspensions were stained with anti–CD25-biotin antibody (7D4), 
followed  by  incubation  with  strepavidin-coupled  MicroBeads  (Miltenyi 
Biotec). The cells were passed twice through a MACS separation column   
(Miltenyi Biotec) to obtain a >95% pure CD25+CD4+ population. 5 × 105 
purified CD25+CD4+ cells were injected i.v. into Rag2/ recipient mice.   
5 × 105 of electronically sorted CD4+CD25CD62-L+ naive T cells were 
coinjected in the indicated mice.
PCR assays. RT-PCR reactions were performed in a 50-µl reaction con-
taining the indicated amounts of genomic DNA, 2 ng/µl of each primer, 0.2 µM 
deoxy-nucleoside triphosphate, 2 mM MgCl2, 50 mM KCl, 10 mM Tris-
HCl, pH 8.8, 0.1% Triton X-100, and 1 U/50 µl Taq polymerase. Reac-
tions were performed for 4 min at 95°C; 35 cycles of 1 min at 95°C, 1 min 
at 57°C, and 1.5 min at 72°C; and 5 min at 72°C.
Real-time RT-PCR was performed using the LightCycler FastStart kit 
(Roche; Espeli et al., 2006) on a LightCycler system. Amounts of RNA 
were calculated by reference to a log-linear standard regression curve. This 
curve was constructed from the number of cycles necessary to detect product 
accumulation after amplification of 2 µl of serial dilutions of a standard 
cDNA solution. The calculation of the relative concentration was performed 
using the LightCycler software (Roche).
Primers  used  were  hypoxanthine-guanine  phosphoribosyltransferase 
(HPRT) forward, 5-CACAGGACTAGAACACCTGC-3; HPRT re-
verse,  5-GCTGGTGAAAAGGACCTCT-3;  IL-2  forward,  5-CCTG-
AGCAGGATGGAGAATTACA-3; IL-2 reverse, 5-GCCTTATGTGT-
TGTAAGCAGGAGG-3; IL-4 forward, 5-TGACGGCACAGAGCTA-
TTGA-3; IL-4 reverse, 5-ATGGTGGCTCAGTACTACGA-3; IL-5 for-
ward, 5-ATGAGGCTTCCTGTCCCTACTC-3; IL-5 reverse, 5-GTCA-
CCATGGAGCAGCTCAGCC-3; IL-10 forward, 5-GGTTGCCAAG-
CCTTATCGGA-3;  IL-10  reverse,  5-ACCTGCTCCACTGCCT-
TGCT-3; IL-13 forward, 5-GGTGCCAAGATCTGTGTCTCTCC-3; 
IL-13  reverse,  5-GAGATGCCCAGGGATGGTCTCC-3;  IFN-  for-
ward, 5-GCTCTGAGACAATGAACGCT-3; IFN- reverse, 5-AAAG-
AGATAATCTGGCTCTGC-3;  Foxp3  forward,  5-CCAAGGATCC-
TACCCACTGCTGG-3; and Foxp3 reverse, 5-CCCAGAGGTGCCT-
CCGCACTGC-3.
Plasmid constructs. The minimal CNS2 region of the Foxp3 gene was PCR 
amplified and cloned into pGL3-Promoter (Promega) to yield pFoxp3CNS2. 2124 Ets-1 is needed for natural T reg cell development | Mouly et al.
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